↓ Skip to main content

PLOS

Down-Regulation of SIX3 is Associated with Clinical Outcome in Lung Adenocarcinoma

Overview of attention for article published in PLOS ONE, August 2013
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
15 Mendeley
Title
Down-Regulation of SIX3 is Associated with Clinical Outcome in Lung Adenocarcinoma
Published in
PLOS ONE, August 2013
DOI 10.1371/journal.pone.0071816
Pubmed ID
Authors

Min-Li Mo, Junichi Okamoto, Zhao Chen, Tomomi Hirata, Iwao Mikami, Geneviève Bosco-Clément, Hui Li, Hai-Meng Zhou, David M. Jablons, Biao He

Abstract

Lung cancer is a common cancer and the leading cause of cancer-related death worldwide. SIX3 is a human homologue of the highly conserved sine oculis gene family essential during embryonic development in vertebrates, and encodes a homeo-domain containing transcription factor. Little is known about the role of SIX3 in human tumorigenesis. This study is to assess the expression/function of SIX3 and the significance of SIX3 as a prognostic biomarker in lung adenocarcinoma.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Mexico 1 7%
Unknown 14 93%

Demographic breakdown

Readers by professional status Count As %
Student > Master 5 33%
Student > Bachelor 2 13%
Student > Ph. D. Student 2 13%
Student > Doctoral Student 1 7%
Professor > Associate Professor 1 7%
Other 1 7%
Unknown 3 20%
Readers by discipline Count As %
Agricultural and Biological Sciences 4 27%
Medicine and Dentistry 3 20%
Biochemistry, Genetics and Molecular Biology 2 13%
Social Sciences 1 7%
Pharmacology, Toxicology and Pharmaceutical Science 1 7%
Other 0 0%
Unknown 4 27%